Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

Workforce Cost Model for Expanding Congenital and Rheumatic Heart Disease Services in Kenya.

Kontchou NT, McCrary AW, Schulman KA.

World J Pediatr Congenit Heart Surg. 2019 May;10(3):321-327. doi: 10.1177/2150135119837201.

PMID:
31084310
2.

The Implications of "Medicare for All" for US Hospitals.

Schulman KA, Milstein A.

JAMA. 2019 Apr 4. doi: 10.1001/jama.2019.3134. [Epub ahead of print] No abstract available.

PMID:
30946429
3.

Toward an Effective Innovation Agenda.

Schulman KA, Richman BD.

N Engl J Med. 2019 Mar 7;380(10):900-901. doi: 10.1056/NEJMp1812460. Epub 2019 Jan 23. No abstract available.

PMID:
30673357
4.

The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.

Schulman KA, Dabora M.

Am Heart J. 2018 Dec;206:113-122. doi: 10.1016/j.ahj.2018.08.006. Epub 2018 Aug 23. Review.

PMID:
30447542
5.

The Evolving Pharmaceutical Benefits Market.

Schulman KA, Richman BD.

JAMA. 2018 Jun 12;319(22):2269-2270. doi: 10.1001/jama.2018.4269. No abstract available.

PMID:
29625496
6.

Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System.

Tseng P, Kaplan RS, Richman BD, Shah MA, Schulman KA.

JAMA. 2018 Feb 20;319(7):691-697. doi: 10.1001/jama.2017.19148.

7.

Trends in hospital-physician integration in medical oncology.

Clough JD, Dinan MA, Schulman KA.

Am J Manag Care. 2017 Oct;23(10):624-627.

8.

Barriers to Achieving Economies of Scale in Analysis of EHR Data. A Cautionary Tale.

Sendak MP, Balu S, Schulman KA.

Appl Clin Inform. 2017 Aug 9;8(3):826-831. doi: 10.4338/ACI-2017-03-CR-0046.

9.

PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability.

Mark DB, Schulman KA.

JAMA. 2017 Aug 22;318(8):711-712. doi: 10.1001/jama.2017.8907. No abstract available.

PMID:
28829851
10.

Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model.

Maniya OZ, Mather RC 3rd, Attarian DE, Mistry B, Chopra A, Strickland M, Schulman KA.

J Arthroplasty. 2017 Nov;32(11):3268-3273.e4. doi: 10.1016/j.arth.2017.05.054. Epub 2017 Jun 8.

PMID:
28669568
11.

The economics of PCSK-9 inhibitors.

Schulman KA, Reed SD.

Am Heart J. 2017 Jul;189:200-201. doi: 10.1016/j.ahj.2017.05.001. Epub 2017 May 4. No abstract available.

PMID:
28625378
12.

Battling the chargemaster: a simple remedy to balance billing for unavoidable out-of-network care.

Richman BD, Kitzman N, Milstein A, Schulman KA.

Am J Manag Care. 2017 Apr 1;23(4):e100-e105.

13.

Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

Levy WC, Li Y, Reed SD, Zile MR, Shadman R, Dardas T, Whellan DJ, Schulman KA, Ellis SJ, Neilson M, O'Connor CM; HFACTION Investigators.

JACC Clin Electrophysiol. 2017 Mar;3(3):291-298. doi: 10.1016/j.jacep.2016.09.006.

14.

Financing and Distribution of Pharmaceuticals in the United States.

Dabora MC, Turaga N, Schulman KA.

JAMA. 2017 Jul 4;318(1):21-22. doi: 10.1001/jama.2017.5607. No abstract available.

PMID:
28505252
15.

A Patient Reported Approach to Identify Medical Errors and Improve Patient Safety in the Emergency Department.

Glickman SW, Mehrotra A, Shea CM, Mayer C, Strickler J, Pabers S, Larson J, Goldstein B, Mandelkehr L, Cairns CB, Pines JM, Schulman KA.

J Patient Saf. 2016 Nov 2. [Epub ahead of print]

PMID:
27811598
16.

Extreme Home Makeover - The Role of Intensive Home Health Care.

Ticona L, Schulman KA.

N Engl J Med. 2016 Nov 3;375(18):1707-1709. No abstract available.

PMID:
27806216
17.

Reassessing ACOs and Health Care Reform.

Schulman KA, Richman BD.

JAMA. 2016 Aug 16;316(7):707-8. doi: 10.1001/jama.2016.10874. No abstract available.

PMID:
27533151
18.

Health Care Tax Inversions--Robbing Both Peter and Paul.

Warraich HJ, Schulman KA.

N Engl J Med. 2016 Mar 17;374(11):1005-7. doi: 10.1056/NEJMp1515769. No abstract available.

PMID:
26981932
19.

Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.

Reed SD, Neilson MP, Gardner M, Li Y, Briggs AH, Polsky DE, Graham FL, Bowers MT, Paul SC, Granger BB, Schulman KA, Whellan DJ, Riegel B, Levy WC.

Am Heart J. 2015 Nov;170(5):951-60. doi: 10.1016/j.ahj.2015.08.015. Epub 2015 Aug 20.

20.

Options to Promote Competitive Generics Markets in the United States.

Wiske CP, Ogbechie OA, Schulman KA.

JAMA. 2015 Nov 24;314(20):2129-30. doi: 10.1001/jama.2015.13498. No abstract available.

PMID:
26513309
21.

Specialty Pharmaceuticals for Hyperlipidemia--Impact on Insurance Premiums.

Schulman KA, Balu S, Reed SD.

N Engl J Med. 2015 Oct 22;373(17):1591-3. doi: 10.1056/NEJMp1509863. Epub 2015 Oct 7. No abstract available.

PMID:
26444460
22.

Patient Preferences for Features of Health Care Delivery Systems: A Discrete Choice Experiment.

Mühlbacher AC, Bethge S, Reed SD, Schulman KA.

Health Serv Res. 2016 Apr;51(2):704-27. doi: 10.1111/1475-6773.12345. Epub 2015 Aug 10.

23.

Enhancing the Value of Statewide Hospital Discharge Data: Improving Clinical Content and Race-Ethnicity Data.

Andrews RM, Schulman KA.

Health Serv Res. 2015 Aug;50 Suppl 1:1265-72. doi: 10.1111/1475-6773.12342. No abstract available.

24.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure.

Dardas T, Li Y, Reed SD, O'Connor CM, Whellan DJ, Ellis SJ, Schulman KA, Kraus WE, Forman DE, Levy WC.

J Heart Lung Transplant. 2015 Aug;34(8):1017-23. doi: 10.1016/j.healun.2015.03.017. Epub 2015 Mar 26.

25.

Market-based solutions to antitrust threats--the rejection of the Partners settlement.

Herzlinger RE, Richman BD, Schulman KA.

N Engl J Med. 2015 Apr 2;372(14):1287-9. doi: 10.1056/NEJMp1501782. Epub 2015 Mar 4. No abstract available.

PMID:
25738542
26.

Review: in adult outpatients, nurse-managed protocols improve hemoglobin A1c levels and blood pressure.

Schulman KA.

Ann Intern Med. 2014 Dec 16;161(12):JC6. doi: 10.7326/0003-4819-161-12-201412160-02006. No abstract available.

PMID:
25506878
27.

Exploring variation in care: alternative conceptual models.

Dinan MA, Schulman KA.

Ann Intern Med. 2014 Dec 2;161(11):835-6. doi: 10.7326/M14-2382. No abstract available.

PMID:
25437412
28.

The impact of specialty pharmaceuticals as drivers of health care costs.

Hirsch BR, Balu S, Schulman KA.

Health Aff (Millwood). 2014 Oct;33(10):1714-20. doi: 10.1377/hlthaff.2014.0558.

PMID:
25288414
29.

Triggering management for quality improvement.

Scales CD Jr, Schulman KA.

Health Serv Res. 2014 Oct;49(5):1401-6. doi: 10.1111/1475-6773.12224. No abstract available.

30.

Removing a constraint on hospital utilization: a natural experiment in Maryland.

Kalman NS, Hammill BG, Murray RB, Schulman KA.

Am J Manag Care. 2014 Jun 1;20(6):e191-9.

31.

An evaluation of mobile health application tools.

Sama PR, Eapen ZJ, Weinfurt KP, Shah BR, Schulman KA.

JMIR Mhealth Uhealth. 2014 May 1;2(2):e19. doi: 10.2196/mhealth.3088.

32.

Can team-based care improve patient satisfaction? A systematic review of randomized controlled trials.

Wen J, Schulman KA.

PLoS One. 2014 Jul 11;9(7):e100603. doi: 10.1371/journal.pone.0100603. eCollection 2014. Review.

33.

Shifting toward defined contributions--predicting the effects.

Schulman KA, Richman BD, Herzlinger RE.

N Engl J Med. 2014 Jun 26;370(26):2462-5. doi: 10.1056/NEJMp1314391. No abstract available.

PMID:
24963565
34.

Organizational characteristics and patient experiences with hospital care: a survey study of hospital chief patient experience officers.

Manary M, Staelin R, Kosel K, Schulman KA, Glickman SW.

Am J Med Qual. 2015 Sep-Oct;30(5):432-40. doi: 10.1177/1062860614539994. Epub 2014 Jun 20.

PMID:
24951105
35.

Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION.

Li Y, Levy WC, Neilson MP, Ellis SJ, Whellan DJ, Schulman KA, O'Connor CM, Reed SD.

J Card Fail. 2014 Aug;20(8):541-7. doi: 10.1016/j.cardfail.2014.05.009. Epub 2014 Jun 2.

36.

Health City Cayman Islands and the globalization of health services delivery.

Shah BR, Narayan M, Seth A, Schulman KA.

Am Heart J. 2014 May;167(5):770-4. doi: 10.1016/j.ahj.2014.02.006. Epub 2014 Feb 26. Review.

PMID:
24766989
37.

Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.

Dinan MA, Curtis LH, Carpenter WR, Biddle AK, Abernethy AP, Patz EF Jr, Schulman KA, Weinberger M.

J Thorac Oncol. 2014 Apr;9(4):512-8. doi: 10.1097/JTO.0000000000000102.

38.

Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).

Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, Califf RM, Rouleau JL, Kober L, White HD, Schulman KA, Reed SD.

JACC Heart Fail. 2014 Apr;2(2):159-65. doi: 10.1016/j.jchf.2013.12.003.

39.

Predicting nursing home placement among home- and community-based services program participants.

Greiner MA, Qualls LG, Iwata I, White HK, Molony SL, Sullivan MT, Burke B, Schulman KA, Setoguchi S.

Am J Manag Care. 2014 Dec 1;20(12):e535-6.

40.

The mis-measure of physician performance.

Glickman SW, Schulman KA.

Am J Manag Care. 2013 Oct;19(10):782-5.

41.

Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.

Reed SD, Kaul P, Li Y, Eapen ZJ, Davidson-Ray L, Schulman KA, Massie BM, Armstrong PW, Starling RC, O'Connor CM, Hernandez AF, Califf RM.

J Card Fail. 2013 Sep;19(9):611-20. doi: 10.1016/j.cardfail.2013.07.003.

PMID:
24054337
42.

Financial incentives in primary care practice: the struggle to achieve population health goals.

Dolor RJ, Schulman KA.

JAMA. 2013 Sep 11;310(10):1031-2. doi: 10.1001/jama.2013.277575. No abstract available.

PMID:
24026597
43.

Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.

Eapen ZJ, Hammill BG, Setoguchi S, Schulman KA, Peterson ED, Hernandez AF, Curtis LH.

J Am Heart Assoc. 2013 Sep 11;2(5):e000242. doi: 10.1161/JAHA.113.000242.

44.

Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial).

Piña IL, Lin L, Weinfurt KP, Isitt JJ, Whellan DJ, Schulman KA, Flynn KE; HF-ACTION Investigators.

Am J Cardiol. 2013 Oct 1;112(7):971-6. doi: 10.1016/j.amjcard.2013.05.033. Epub 2013 Jun 27.

PMID:
23809621
45.

Systemic and Ocular Risks Associated With Therapies for Macular Degeneration: Clarification vs Confusion-Reply.

Curtis LH, Hammill BG, Schulman KA, Cousins SW.

Arch Ophthalmol. 2012 Jun;130(6):806-7. doi: 10.1001/archophthalmol.2012.100. No abstract available.

PMID:
23753704
46.

The economics of new drugs: can we afford to make progress in a common disease?

Hirsch BR, Schulman KA.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e126. Review.

47.

Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov.

Hirsch BR, Califf RM, Cheng SK, Tasneem A, Horton J, Chiswell K, Schulman KA, Dilts DM, Abernethy AP.

JAMA Intern Med. 2013 Jun 10;173(11):972-9. doi: 10.1001/jamainternmed.2013.627. Erratum in: JAMA Intern Med. 2013 Sep 9;173(16):1560.

PMID:
23699837
48.

Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION.

Li Y, Neilson MP, Whellan DJ, Schulman KA, Levy WC, Reed SD.

J Card Fail. 2013 May;19(5):311-6. doi: 10.1016/j.cardfail.2013.03.008.

49.

Reply to M.S. Hofman et al.

Dinan MA, Carpenter WR, Patz EF Jr, Abernethy AP, Biddle AK, Schulman KA, Curtis LH.

J Clin Oncol. 2013 Feb 20;31(6):820. No abstract available.

PMID:
23544205
50.

Invited Commentary-Can We Begin With the End in Mind? End-of-Life Care Preferences Before Long-term Dialysis.

Patel UD, Schulman KA.

Arch Intern Med. 2012 Apr 23;172(8):663-4. doi: 10.1001/archinternmed.2012.1151. No abstract available.

PMID:
23446995

Supplemental Content

Loading ...
Support Center